Signalling by protein phosphatases and drug development: a systems-centred view

Lan K Nguyen, David Matallanas, David R Croucher, Alex Von Kriegsheim, Boris N Kholodenko

Research output: Contribution to journalArticlepeer-review

Abstract

Protein modification cycles catalysed by opposing enzymes, such as kinases and phosphatases, form the backbone of signalling networks. Although, historically, kinases have been at the research forefront, a systems-centred approach reveals predominant roles for phosphatases in controlling the network response times and spatio-temporal profiles of signalling activities. Emerging evidence suggests that phosphatase kinetics are critical for network function and cell-fate decisions. Protein phosphatases operate as both immediate and delayed regulators of signal transduction, capable of attenuating or amplifying signalling. This versatility of phosphatase action emphasizes the need for systems biology approaches to understand cellular signalling networks and predict the cellular outcomes of combinatorial drug interventions.

Original languageEnglish
Pages (from-to)751-65
Number of pages15
JournalThe FEBS Journal
Volume280
Issue number2
DOIs
Publication statusPublished - 14 Mar 2012

Keywords / Materials (for Non-textual outputs)

  • Drug Discovery
  • Enzyme Inhibitors
  • Humans
  • Phosphoprotein Phosphatases
  • Signal Transduction
  • Systems Biology

Fingerprint

Dive into the research topics of 'Signalling by protein phosphatases and drug development: a systems-centred view'. Together they form a unique fingerprint.

Cite this